Oculus Myopia Master , Ref 68100, CE 0123 — FDA record Z-2484-2023

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Aug 8, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Oculus Myopia Master , Ref 68100, CE 0123
Reason
Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect axial length measurements.
Classification
Class II
Recalling firm
Oculus Optikgeraete GMBH
Quantity
173 units
Agency-reported status
Ongoing
Source record identifier
Z-2484-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI-DI; (01) 04049584026095

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide distribution in the states of CA, FL, MA, MN, NY, NC, OH, PA, TX, VA, WA. OUS: Not Provided

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Sep 6, 2023
Recall initiation date
Aug 8, 2023
Center classification date
Aug 30, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records